Medical Device News Magazine

Omeza Announces Appointment of Brad Scheckner as VP, Field Sales and Operations

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Omeza, a regenerative skincare company that develops marine-based therapies for the treatment of chronic wounds, today announced the appointment of Brad Scheckner as Vice President, Field Sales and Operations.

“Omeza’s rapid ascent from a start-up with a promising concept to a commercial-stage company with an FDA-approved product is a testament to our scientific acumen, robust clinical data, and sound operational infrastructure — one that we continue to build and grow with new talent,” said Cynthia Flowers, Chief Executive Officer of Omeza.

“We’re thrilled to have Brad at the helm of our field force to create a culture of empowerment that drives the team to surpass sales targets and generate substantial revenue. His proven success in building teams and launching products is critical as we realize the potential of Omeza’s suite of wound-care products.”

Brad Scheckner brings more than two decades of experience across biopharmaceutical, diagnostic, and medical device companies, including field sales and leadership positions at Genzyme, Sanofi, Crescendo Bioscience, Flexion Therapeutics, and Electromedical Products International. He possesses significant cross-functional expertise in strategic marketing, market and payer access, business analytics, and business development as well as extensive knowledge of target healthcare settings, from specialty practices and ambulatory surgical centers to Veterans Affairs hospitals and the Department of Defense.

Throughout his career, he has built and led multiple first-line management and sales teams, overseeing four product launches across various disease states. Additionally, Mr. Scheckner has served in multiple leadership roles in which he has liaised with marketing, business analytics, and employee engagement teams to develop a cohesive strategic approach that aligns the organization with sales in the pursuit of common goals and objectives.

Mr. Scheckner is a graduate of Florida State University, where he earned his degree in Business Management. He currently resides in Sarasota, Fla.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”